These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38904089)

  • 1. Metabolomics for searching validated biomarkers in cancer studies: a decade in review.
    López-López Á; López-Gonzálvez Á; Barbas C
    Expert Rev Mol Diagn; 2024 Jul; 24(7):601-626. PubMed ID: 38904089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics: a revolution for novel cancer marker identification.
    Bu Q; Huang Y; Yan G; Cen X; Zhao YL
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of metabolomics in oncology: a review.
    Spratlin JL; Serkova NJ; Eckhardt SG
    Clin Cancer Res; 2009 Jan; 15(2):431-40. PubMed ID: 19147747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.
    Long NP; Yoon SJ; Anh NH; Nghi TD; Lim DK; Hong YJ; Hong SS; Kwon SW
    Metabolomics; 2018 Aug; 14(8):109. PubMed ID: 30830397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of validated biomarkers obtained through metabolomics.
    López-López Á; López-Gonzálvez Á; Barker-Tejeda TC; Barbas C
    Expert Rev Mol Diagn; 2018 Jun; 18(6):557-575. PubMed ID: 29808702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCMMD: systematic evaluation of metabolites in body fluids as liquid biopsy biomarker for human cancers.
    Dong X; Qu Y; Sheng T; Fan Y; Chen S; Yuan Q; Ma G; Ge Y
    Aging (Albany NY); 2024 Apr; 16(8):7487-7504. PubMed ID: 38683118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the metabolomic study of bladder cancer.
    Amara CS; Vantaku V; Lotan Y; Putluri N
    Expert Rev Proteomics; 2019 Apr; 16(4):315-324. PubMed ID: 30773067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics in cell culture--a strategy to study crucial metabolic pathways in cancer development and the response to treatment.
    Halama A
    Arch Biochem Biophys; 2014 Dec; 564():100-9. PubMed ID: 25218088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
    Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
    Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Metabolic Biomarkers in Cancer Patients: An Overview.
    De Matteis S; Bonafè M; Giudetti AM
    Methods Mol Biol; 2021; 2292():203-212. PubMed ID: 33651364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics for mitochondrial and cancer studies.
    Nagrath D; Caneba C; Karedath T; Bellance N
    Biochim Biophys Acta; 2011 Jun; 1807(6):650-63. PubMed ID: 21420931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics: A Tool to Envisage Biomarkers in Clinical Interpretation of Cancer.
    Bhalla M; Mittal R; Kumar M; Bhatia R; Kushwah AS
    Curr Drug Res Rev; 2024; 16(3):333-348. PubMed ID: 37702236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncometabolomics in cancer research.
    Gupta S; Chawla K
    Expert Rev Proteomics; 2013 Aug; 10(4):325-36. PubMed ID: 23992416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in metabolomics profiling of pediatric kidney diseases: A review.
    Huang G
    Biomol Biomed; 2024 Sep; 24(5):1044-1054. PubMed ID: 38400839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and opportunities of metabolomics.
    Johnson CH; Gonzalez FJ
    J Cell Physiol; 2012 Aug; 227(8):2975-81. PubMed ID: 22034100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Opportunities in Cancer Metabolomics.
    Kumar A; Misra BB
    Proteomics; 2019 Nov; 19(21-22):e1900042. PubMed ID: 30950571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational metabolomics in cancer research.
    Snyder NW; Mesaros C; Blair IA
    Biomark Med; 2015; 9(9):821-34. PubMed ID: 26329905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical appraisal of the role of metabolomics in breast cancer research and diagnostics.
    Gadwal A; Panigrahi P; Khokhar M; Sharma V; Setia P; Vishnoi JR; Elhence P; Purohit P
    Clin Chim Acta; 2024 Jul; 561():119836. PubMed ID: 38944408
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.